Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest announcement is out from ADICON Holdings Limited ( (HK:9860) ).
ADICON Holdings Limited has issued a supplemental progress update on its planned acquisition of 100% of the issued shares of Crown Bioscience International. The company now expects to send a circular to shareholders on or before September 30, 2026, and will provide further updates as the transaction advances.
The acquisition remains subject to the satisfaction of specified conditions, meaning the deal may or may not proceed. ADICON has urged shareholders and potential investors to exercise caution when dealing in its securities while the outcome of the transaction is still uncertain.
The most recent analyst rating on (HK:9860) stock is a Buy with a HK$7.00 price target. To see the full list of analyst forecasts on ADICON Holdings Limited stock, see the HK:9860 Stock Forecast page.
More about ADICON Holdings Limited
ADICON Holdings Limited is a Hong Kong-listed company incorporated in the Cayman Islands. It operates in the healthcare and life sciences sector, and is expanding its portfolio through strategic acquisitions, including a proposed purchase of Crown Bioscience International.
Average Trading Volume: 1,058,708
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.03B
Find detailed analytics on 9860 stock on TipRanks’ Stock Analysis page.